GambettiPParchiP. Insomnia in prion disease: Sporadic and familial. Editorials. N Engl J Med1999: 340; 1675–1677.
2.
MastrianniJANizonRTellingGC. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med1999: 340; 1630–1638.
3.
HsiehGKenneyKGibbsCJ. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med1996; 335: 924–930.
4.
CreuzfeldtHG. Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Neural Psychiatr1920; 57: 1–9.
5.
Prusiner SVB.Prion diseases and the BSE crisis. Science1997; 278: 245–251.
6.
GradyD. Ironing out the wrinkles in the prion strain problem. Science1996; 274: 2079–2082.
7.
KretzschmarHAIronsideJWDeArmondSJ. Diagnostic criteria for Creutzfeldt-Jakob disease. Arch Neurol1996; 9: 913–920.
8.
BrownP. The risk of bovine spongiform encephalopathy (‘mad cow disease’) to human health. JAMA278; 1997: 1008–1011.
9.
WillRGIronsideJWZeidlerM. A new variant of Creuzfeldt-Jakob disease in the U.K. Lancet. 1996; 347: 921–925.
SteinhoffBJRackerSHerrendorfG. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol1996; 53: 162–166.
12.
BrownP. Environmental causes of human spongiform encephalopathy. In: BakerHRidgelyR (eds). Methods in Molecular Medicine: Prion Diseases. Totowa, NJ: Humana Press; 1996; 139–154.
13.
BernadPG. Creutzfeldt-Jakob disease, human growth hormone and its replacement with synthetic growth hormone. Proceedings of the Third International Conference on Pharmacoepidemiology. 1987; University of Minnesota, Minneapolis.
14.
BernadPG. Guidelines: Relevance of infectious diseases for the electroencephalogram and other neurophysiology laboratories. Clin Electroencephalogr1989; 20(3): VIII–X.